Cronos Group Shares Slightly Up After Announcing Purchase Of 10.5% Stake In PharmaCann For $110.4M
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is poised to acquire a stake in PharmaCann for approximately $110.4 million.
‘Texas And Louisiana Governors Signal They’ll Sign Marijuana Reform Bills On Their Desks’ -Marijuana Moment
https://www.marijuanamoment.net/texas-and-louisiana-governors-signal-theyll-sign-marijuana-reform-bills-on-their-desks/
Cronos Group, Ginkgo Bioworks Modify Agreement To Speed Up Commercialization of Cultured Cannabinoids
Cannabinoid company Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is amending its previous partnership agreement with Ginkgo Bioworks, Inc., a company involved in cell programming.
Cronos Group Reports Amended Deal With Ginkgo Bioworks To Accelerate Commercialization Of Cultered Cannabinoids; Cronos Begins Commercial Production Of Cannabigerol
Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) (“Cronos Group”), an innovative global cannabinoid company, and Ginkgo Bioworks, Inc. (“Ginkgo”), which is building the leading horizontal platform for
Cannabis Stock Gainers And Losers From June 3, 2021
GAINERS:
MGC Pharmaceuticals (OTC: MGCLF) shares closed up 17.65% at $0.04
Cannabis Stock Gainers And Losers From June 2, 2021
GAINERS:
Sundial Growers (NASDAQ: SNDL) shares closed up 13% at $1.13
Cannabis Stock Gainers And Losers From May 28, 2021
GAINERS:
Canada House Wellness (OTC: SARSF) shares closed up 23.72% at $0.03
‘Fast Money Halftime Report’ Picks For May 28
On CNBC's "Fast Money Halftime Report," Stephanie Link said she is doubling down on Anaplan Inc (NYSE: PLAN).